20 November 2025

Researchers at Linköping University will share SEK 12 million for new projects to improve treatment and quality of life for cancer patients. One of them is Henrik Green, who researches how genetic differences between patients can affect how they react to cancer treatment.

Photographer: Emma Busk Winquist

In 2025, the Swedish Cancer Society will give more than SEK 1 billion to Swedish cancer research, the largest amount ever, according to their press release.
One of the projects receiving funding is led by Professor Henrik Green, professor at the Department of Biomedical and Clinical Sciences (BKV), who researches how genetic differences between patients can affect reactions to cancer treatment. The aim is to be able to predict which patients are at risk of severe side effects of chemotherapy, to achieve more accurate and gentle treatment.

“Everyone reacts differently to cancer treatment. Some people can manage chemotherapy without problems, while others suffer life-threatening side effects after the first course of treatment. The goal is to be able to adapt doses and treatment based on each individual’s genetic profile,” says Henrik Green.

Personalised treatment

Green’s research team will sequence patients’ DNA and use AI to build models that can identify which patients are most at risk of side effects. By combining genetic information with laboratory studies, they hope to create models to be used directly in health care. For this purpose, they now receive SEK 3 million from the Swedish Cancer Society.
“This project is a clear example of how research can make health care more individualised. Being able to predict which patients are at risk of severe side effects will ensure that more people get the right treatment from the start – with better results and quality of life,” says Professor Malin Sund, Chair of the Swedish Cancer Society’s Research Board.

SEK 12 million to BKV’s research

Other than Henrik Green, three researchers at the Department of Biomedical and Clinical Sciences receive funding from the Swedish Cancer Society for their research projects:

  • Judith Arvelund receives funding for the project Virus-based immunotherapy for the treatment of lymphomas – Characterizing tissue-specific resistance mechanisms.
  • Anna Fahlgren, for the project The role of shear stress in promoting secondary metastases of bone-metastatic breast cancer to the lung and liver.
  • Johanna Ungerstedt, for the project Indepth molecular characterization of genotype, phenotype and microenvironment in Chronic Myelomonocytic Leukemia to delineate disease onset mechanisms and the role of chronic inflammation.

Researchers who receive grants from the Swedish Cancer Society

En person i labbrock som håller i en flaska.

AI provides a more precise time of death

Artificial intelligence can be used to provide a more precise time of death, which can be crucial in e.g. murder investigations. The AI model is trained on so-called metabolites in thousands of blood samples from real deaths.

Man wearing a lab coat holds a test tube containing two green pills.

From lab to legislation – the fight against new online drugs

A new drug on the European market – every week. Professor Henrik Green is using research to help government agencies stop the most dangerous online drugs more quickly.

Henrik Green.

Nerve damage from cancer treatment can be predicted

Many women treated for breast cancer using taxanes, a type of cytostatic drug, often experience side effects in the nervous system. Researchers at LiU have developed a tool that can predict the risk level for each individual.

Latest news from LiU

A woman sleeping on a bed with a pillow.

New insights aided recovery from persistent fatigue

Researchers have identified common steps and turning points in stories of patients who have recovered from diagnoses characterised by persistent fatigue. The findings can contribute to new ways of understanding and rehabilitating these conditions.

En man som sitter i en stol på ett kontor.

Increased risk of bullying in open-plan offices

Open-plan offices entail a clearly increased risk of workplace bullying compared with employees having their own office or sharing with just a few colleagues. This is shown in research from Linköping University.

A man standing in a lab.

Prestigious chemistry award to Simone Fabiano

This year’s Göran Gustafsson Prize in Chemistry is awarded to LiU Professor Simone Fabiano. His research focuses on organic semiconductors and how so‑called doping can improve conductivity and yield new properties.